Equity Analyst - Asia Consumer Sector, Investory

Devi Subhakesan

Equity Research experience of over 20 years include working at leading Asset Management and Brokerage/Investment Banking Firms.  

I focus primarily on the Asia consumer sector and analyse emerging trends and evolving consumption behaviours to publish investment insights on segments where women and/or youth drive purchasing decisions.

My approach combines in-depth industry and company research with rigorous valuation analysis to help investors make informed investment decisions.

Equity Analyst - Asia Consumer Sector

ASIA CONSUMER: INSIGHTS AND INVESTMENT IDEAS

Investory

Investory is a Singapore-based boutique independent equity research firm founded in January 2017 with a primary focus on consumption themes across Asia-Pacific.

We aim to generate investible ideas based on consumption trends and outlook. We screen our ideas on several parameters - product potential, long-term growth and management commitment being the most critical.  We follow a fundamental analysis approach in our stock selection process and are not restricted by market cap.

We aspire to grow into a leading source of unbiased research, free of conflict of interest, for investors yearning for independent and disciplined analysis. 

We also undertake bespoke research mandates to support our Institutional clients’ investment needs.

Our team comprises of professionals with extensive experience in the Asian equity markets, in areas ranging from research, servicing institutional clients and investment management.

Equity Bottom-Up

Health And Happiness (H&H) / Equity Bottom-Up

<ul>
<li>After sinking to 10-year lows in January,  <a href="https://www.smartkarma.com/entities/health-and-happiness-h-h-int" target="_blank" data-smartkarma-citation="entities:20582:1" rel="noopener">Health And Happiness (H&amp;H)</a> ’s stock has rebounded more than 75%, raising the question of whether operations are finally turning the corner.</li>
<li>With signs of stabilizing growth and improving returns across product categories, 1H2025 results seem to signal the end of years of investor agony.</li>
<li>Nutritional supplements now contribute to 65% of H&amp;H's revenue - Swisse’s strong positioning in the fast-growing anti-aging category underpins future growth.</li>
</ul>


After sinking to 10-year lows in January,  Health And Happiness (H&amp;H) ’s stock has rebounded more than 75%, raising the question of whether operations are finally turning the corner.
With signs of stabilizing growth and improving returns across product categories, 1H2025 results seem to signal the end of years of investor agony.
Nutritional supplements now contribute to 65% of H&amp;H's revenue - Swisse’s strong positioning in the fast-growing anti-aging category underpins future growth.


Health & Happiness (H&H 1112HK): After the Pain, Is It Finally Time for Gain?